UniProt ID | CSF3R_HUMAN | |
---|---|---|
UniProt AC | Q99062 | |
Protein Name | Granulocyte colony-stimulating factor receptor | |
Gene Name | CSF3R | |
Organism | Homo sapiens (Human). | |
Sequence Length | 836 | |
Subcellular Localization |
Isoform 2: Secreted . Cell membrane Single-pass type I membrane protein . |
|
Protein Description | Receptor for granulocyte colony-stimulating factor (CSF3), essential for granulocytic maturation. Plays a crucial role in the proliferation, differientation and survival of cells along the neutrophilic lineage. In addition it may function in some adhesion or recognition events at the cell surface.. | |
Protein Sequence | MARLGNCSLTWAALIILLLPGSLEECGHISVSAPIVHLGDPITASCIIKQNCSHLDPEPQILWRLGAELQPGGRQQRLSDGTQESIITLPHLNHTQAFLSCCLNWGNSLQILDQVELRAGYPPAIPHNLSCLMNLTTSSLICQWEPGPETHLPTSFTLKSFKSRGNCQTQGDSILDCVPKDGQSHCCIPRKHLLLYQNMGIWVQAENALGTSMSPQLCLDPMDVVKLEPPMLRTMDPSPEAAPPQAGCLQLCWEPWQPGLHINQKCELRHKPQRGEASWALVGPLPLEALQYELCGLLPATAYTLQIRCIRWPLPGHWSDWSPSLELRTTERAPTVRLDTWWRQRQLDPRTVQLFWKPVPLEEDSGRIQGYVVSWRPSGQAGAILPLCNTTELSCTFHLPSEAQEVALVAYNSAGTSRPTPVVFSESRGPALTRLHAMARDPHSLWVGWEPPNPWPQGYVIEWGLGPPSASNSNKTWRMEQNGRATGFLLKENIRPFQLYEIIVTPLYQDTMGPSQHVYAYSQEMAPSHAPELHLKHIGKTWAQLEWVPEPPELGKSPLTHYTIFWTNAQNQSFSAILNASSRGFVLHGLEPASLYHIHLMAASQAGATNSTVLTLMTLTPEGSELHIILGLFGLLLLLTCLCGTAWLCCSPNRKNPLWPSVPDPAHSSLGSWVPTIMEEDAFQLPGLGTPPITKLTVLEEDEKKPVPWESHNSSETCGLPTLVQTYVLQGDPRAVSTQPQSQSGTSDQVLYGQLLGSPTSPGPGHYLRCDSTQPLLAGLTPSPKSYENLWFQASPLGTLVTPAPSQEDDCVFGPLLNFPLLQGIRVHGMEALGSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
51 | N-linked_Glycosylation | ASCIIKQNCSHLDPE HHHEEECCCCCCCCC | 25.02 | 8855939 | |
51 | N-linked_Glycosylation | ASCIIKQNCSHLDPE HHHEEECCCCCCCCC | 25.02 | 8855939 | |
93 | N-linked_Glycosylation | IITLPHLNHTQAFLS EEECCCCCHHHHHHH | 32.88 | 8855939 | |
93 | N-linked_Glycosylation | IITLPHLNHTQAFLS EEECCCCCHHHHHHH | 32.88 | 8855939 | |
128 | N-linked_Glycosylation | YPPAIPHNLSCLMNL CCCCCCCCHHHHHHC | 28.44 | 8855939 | |
128 | N-linked_Glycosylation | YPPAIPHNLSCLMNL CCCCCCCCHHHHHHC | 28.44 | 8855939 | |
134 | N-linked_Glycosylation | HNLSCLMNLTTSSLI CCHHHHHHCCCCCCE | 22.68 | 16492764 | |
134 | N-linked_Glycosylation | HNLSCLMNLTTSSLI CCHHHHHHCCCCCCE | 22.68 | 16492764 | |
160 | Phosphorylation | PTSFTLKSFKSRGNC CCEEEEEEHHHCCCC | 40.81 | 24719451 | |
196 | Phosphorylation | PRKHLLLYQNMGIWV ECCEEEEEECCEEEE | 9.60 | - | |
324 | Phosphorylation | HWSDWSPSLELRTTE CHHHCCCCEEEEECC | 29.03 | 24719451 | |
351 | Phosphorylation | QRQLDPRTVQLFWKP HCCCCCCEEEEEEEE | 20.28 | - | |
365 | Phosphorylation | PVPLEEDSGRIQGYV EEECCCCCCCEEEEE | 33.00 | 27732954 | |
389 | N-linked_Glycosylation | GAILPLCNTTELSCT CCEEECCCCCEEEEE | 58.69 | 8855939 | |
389 | N-linked_Glycosylation | GAILPLCNTTELSCT CCEEECCCCCEEEEE | 58.69 | 8855939 | |
401 | Phosphorylation | SCTFHLPSEAQEVAL EEEEECCCCCCEEEE | 52.50 | 24275569 | |
413 | Phosphorylation | VALVAYNSAGTSRPT EEEEEECCCCCCCCC | 18.52 | 24275569 | |
416 | Phosphorylation | VAYNSAGTSRPTPVV EEECCCCCCCCCCEE | 22.68 | 24275569 | |
420 | Phosphorylation | SAGTSRPTPVVFSES CCCCCCCCCEEEECC | 27.83 | 24275569 | |
425 | Phosphorylation | RPTPVVFSESRGPAL CCCCEEEECCCCCHH | 24.05 | 24275569 | |
427 | Phosphorylation | TPVVFSESRGPALTR CCEEEECCCCCHHHH | 41.14 | 24275569 | |
474 | N-linked_Glycosylation | PPSASNSNKTWRMEQ CCCCCCCCCCEEEEE | 50.45 | 8855939 | |
474 | N-linked_Glycosylation | PPSASNSNKTWRMEQ CCCCCCCCCCEEEEE | 50.45 | 8855939 | |
571 | N-linked_Glycosylation | IFWTNAQNQSFSAIL EEEECCCCCCHHHHH | 36.73 | 8855939 | |
571 | N-linked_Glycosylation | IFWTNAQNQSFSAIL EEEECCCCCCHHHHH | 36.73 | 8855939 | |
579 | N-linked_Glycosylation | QSFSAILNASSRGFV CCHHHHHCCCCCCEE | 31.50 | 8855939 | |
579 | N-linked_Glycosylation | QSFSAILNASSRGFV CCHHHHHCCCCCCEE | 31.50 | 8855939 | |
610 | N-linked_Glycosylation | ASQAGATNSTVLTLM HHHCCCCCCEEEEEE | 34.84 | 8855939 | |
610 | N-linked_Glycosylation | ASQAGATNSTVLTLM HHHCCCCCCEEEEEE | 34.84 | 8855939 | |
655 | Ubiquitination | LCCSPNRKNPLWPSV HHCCCCCCCCCCCCC | 70.34 | 19453968 | |
681 (in isoform 2) | Phosphorylation | - | 39.10 | 22210691 | |
684 (in isoform 2) | Phosphorylation | - | 48.76 | 22210691 | |
695 | Ubiquitination | LGTPPITKLTVLEED CCCCCCCEEEEEECC | 42.77 | 19453968 | |
704 | Ubiquitination | TVLEEDEKKPVPWES EEEECCCCCCCCCCC | 74.77 | 19453968 | |
705 | Ubiquitination | VLEEDEKKPVPWESH EEECCCCCCCCCCCC | 49.56 | 1945396 | |
727 | Phosphorylation | LPTLVQTYVLQGDPR CCCEEEEEEECCCCC | 5.10 | 12133942 | |
752 | Phosphorylation | GTSDQVLYGQLLGSP CCCCCEEEEEHHCCC | 12.17 | 12133942 | |
767 | Phosphorylation | TSPGPGHYLRCDSTQ CCCCCCCEEECCCCC | 11.19 | 16493051 | |
772 | Phosphorylation | GHYLRCDSTQPLLAG CCEEECCCCCCEECC | 32.35 | 28509920 | |
773 | Phosphorylation | HYLRCDSTQPLLAGL CEEECCCCCCEECCC | 22.43 | 28509920 | |
781 | Phosphorylation | QPLLAGLTPSPKSYE CCEECCCCCCCCCHH | 22.32 | 28509920 | |
783 | Phosphorylation | LLAGLTPSPKSYENL EECCCCCCCCCHHCC | 39.46 | 28509920 | |
787 | Phosphorylation | LTPSPKSYENLWFQA CCCCCCCHHCCEEEE | 18.24 | 8547634 | |
835 | Phosphorylation | HGMEALGSF------ CCHHHCCCC------ | 28.74 | 28450419 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSF3R_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSF3R_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
JAK1_HUMAN | JAK1 | physical | 7512720 | |
LYN_HUMAN | LYN | physical | 8197119 | |
KSYK_HUMAN | SYK | physical | 8197119 | |
FZR1_HUMAN | FZR1 | physical | 17001306 | |
WSB1_HUMAN | WSB1 | physical | 17001306 | |
WSB2_HUMAN | WSB2 | physical | 17001306 | |
SHC1_HUMAN | SHC1 | physical | 17001306 | |
GRB2_HUMAN | GRB2 | physical | 17001306 | |
CISH_HUMAN | CISH | physical | 15470047 | |
FBXW7_HUMAN | FBXW7 | physical | 23820376 | |
GSK3B_HUMAN | GSK3B | physical | 23820376 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
162830 | Hereditary neutrophilia (NEUTROPHILIA) | |||||
Kegg Drug | ||||||
D03235 | Filgrastim (genetical recombination) (JP16); Filgrastim (USAN/INN); Filgrastim (genetical recombinat | |||||
D03245 | Nartograstim (genetical recombination) (JP16); Nartograstim (INN) | |||||
D03247 | Lenograstim (genetical recombination) (JP16); Lenograstim (USAN/INN); Neutrogin (TN) | |||||
D04695 | Leridistim (USAN/INN) | |||||
D05036 | Milodistim (USAN/INN); Pixykine (TN) | |||||
D05389 | Pegnartograstim (USAN/INN) | |||||
D06889 | Pegfilgrastim (genetical recombination) (JAN); Pegfilgrastim (INN); Neulasta (TN) | |||||
D10242 | Lipegfilgrastim (USAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex."; Tamada T., Honjo E., Maeda Y., Okamoto T., Ishibashi M., Tokunaga M.,Kuroki R.; Proc. Natl. Acad. Sci. U.S.A. 103:3135-3140(2006). Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-333 IN COMPLEX WITH CSF3,GLYCOSYLATION AT ASN-134, DISULFIDE BONDS, AND SUBUNIT. |